echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Huahai Pharmaceutical Sitagliptin Phosphate Tablets Received Acceptance from CDE

    Huahai Pharmaceutical Sitagliptin Phosphate Tablets Received Acceptance from CDE

    • Last Update: 2021-04-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today (March 23), Huahai Pharmaceutical was accepted by CDE for its imitation of Sitagliptin Phosphate Tablets of Type 4 application.


    Sitagliptin is a potent and highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor developed by Merck.


    The sales of sitagliptin on the terminal of public medical institutions in China

    Source: Mi Nei.


    According to Meinenet data, in 2019, China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (referred to as Chinese public medical institutions) terminal sitagliptin sales approached 1 billion yuan; in 2020H1, its sales increased by 15.


    Sitagliptin Phosphate Tablets Approval Enterprise Under Review

    Source: Meinenet MED2.


    At present, the only companies approved for sitagliptin phosphate tablets in the domestic market are Merck and Dongyang Pharmaceutical, and Chia Tai Tianqing Pharmaceutical Group.


    Source: Minet database

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.